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MANY IMMUNOLOGICAL ABNORMALITIES
are described in the peripheral blood of
patients with Hodgkin's disease (HD)
(Twomey & Rice, 1980), but relatively
few studies have recorded the functional
activity of lymphoid cells extracted from
biopsy tissue of patients with this lym-
phoma. An elevation in the percentage of
T lymphocytes is well described in
involved and uninvolved spleens and
lymph nodes from patients with HD
(Kaur et al., 1974; de Sousa et al., 1977).
The presence of many lymphoblasts
(Payne et al., 1976) and increased spon-
taneous immunoglobulin (Ig) production
(Longmire et al., 1973; Jones et al., 1977)
in uninvolved spleens provides evidence
of lymphocyte activation in HD and
implies functional changes in the spleen
before disease involvement. In this study
we have undertaken a further investiga-
tion of splenic lymphoreticular function
in HD. Mononuclear cells have been
tested for their ability to kill the cell
line K562, a functional measure of the
activity of natural killer (NK) lympho-
cytes (Ortaldo et al., 1979).
Fresh spleen tissue was obtained at
staging laparotomy from patients with
Hodgkin's lymphoma, 15 without and 3
with histological evidence of disease in-
volvement. The patients' ages ranged
from 11 to 60 years (mean 26 6 years).
Twenty control spleens (age range 15-75
years, mean 49-4 years) were obtained
after traumatic rupture or from patients
undergoing abdominal surgery for non-
malignant conditions.
Heparinized venous blood was obtained
from 25 healthy adult controls (hospital
staff). The method of preparation of
spleen mononuclear cells has been des-
cribed in detail previously (Payne et al.,
1976); all culture reagents were purchased
from Gibco Europe Ltd. Fresh spleen
tissue was dispersed in medium, filtered
through gauze and layered over Ficoll-
Triosil (Thorsby & Bratilie, 1978). Mono-
nuclear cells were removed from the
interface after centrifugation at 400 g for
30 min, washed x 3 in calcium- and
magnesium-free Hanks' balanced salt solu-
tion (CMFHBS, 150 g, 10 min) and made
up to working concentrations in complete
RPMI 1640 containing 10% heat-inacti-
vated foetal bovine serum (SRPMI).
Peripheral blood cells were similarly
prepared by centrifugation through Ficoll-
Triosil. Cells thus prepared were > 9500
viable and contained 0-2% contaminating
granulocytes. The erythromyeloid cell
line K562 (Lozzio & Lozzio, 1975; a gift
of Professor E. Klein, Karolinska Insti-
tute, Stockholm, Sweden) was labelled
with 100 ,tCi and sodium 51Cr chromate
(Amersham International CJSI) in a
small volume of medium for 45 min at
37TC, washed x 3 and taken into SRPMI.
Each target-cell preparation was tested
for efficiency of labelling, cell count, and
viability before assay.
Cytotoxicity assays.-Cytotoxicity was
measured after the method of Kohl et al.
(1977). Replicate dilutions of effector
cells were tested in rigid polystyrene
V-bottomed microtitre plates (SterilinNK ACTIVITY IN HODGKIN'S AND NORMAL SPLEENS
Ltd, Richmond, Surrey, U.K.). For the
cytotoxic assay 100 [lI of target-cell sus-
pension was mixed with 100 /d of effector
cells at a concentration sufficient to give
the required effector: target (E: T) ratio.
The plate was then spun at 200 g for 5
min and incubated for 4 h at 37TC. At
the end of the incubation period plates
were recentrifuged and 100 [I of super-
natant removed for gamma counting.
Values for spontaneous release were ob-
tained by incubating cells with medium
alone and for detergent release by incuba-
tion of 100 [I of targets with 100 pl of
non-ionic detergent. Specific cytotoxicity
for each E: T ratio tested was calculated
by the formula:
Mean 51Cr release in test
-Mean 51Cr release in medium
Mean 51Cr release in detergent
-Mean 51Cr release in medium
Rosetting assays were performed on fresh
mononuclear cells as discussed previously
(Payne et al., 1976, 1980). ox-Naphthyl
acetate esterase staining for monocyte
identification was performed on fixed
cytocentrifuge preparations of effector
cells (Yam et al., 1971).
The results were as follows,
(a) Uninvolved spleens.-Mononuclear
cells prepared from 14 HD spleens showed
a significant increase in NK activity at all
E: T ratios when compared with similarly
prepared effectors from the control series
(Fig.). The greatest increase in activity
was noted at an E: T ratio of 20: 1. In
a further 4 cases, where NK cytotoxicity
was measured at this E: T ratio only,
activity was similarly elevated. The Table
presents the NK values for control and
all HD patients at an E: T ratio of 20: 1.
(b) Involved spleen8.-The presence of
histologically recognizable tumour in the
spleen or of constitutional (B) symptoms
was associated with a reduction in NK
activity (Table) in comparison with un-
involved spleens from asymptomatic
patients.
(c) Cell-marker studies.-The percent-
age ofesterase-positive macrophages (Yam
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FiG. NK activity of mononuclear cells from
control and HD patients' spleens. Points
represent mean + 1 s.e. Control series are
values. Significance* 1:10, P= <0Ol;
lower l:20, P= <0.01; 1:40, P= <0O001;
1:80, P= <0001.
* Calculated by Student's t test.
et al., 1971) varied from 2 to 10 and from
3 to 14% in control and patient groups
respectively and did not correlate with
the lysis of target cells. Values for spon-
taneous sheep red blood cell rosettes (E
rosettes) are presented in the Table and
do not relate to NK levels.
Surface-marker studies ofcells extracted
from HD tissue early in the disease pro-
cess show changes in the lymphocyte
populations present in spleen and lymph
node. The presence of lymphoblasts
(Payne et al., 1976) and changes in PHA
responsiveness and levels of Ig production
(Kaur et al., 1974; Longmire et al., 1973;
Jones et al., 1977) suggest the sequestra-
tion of functional subsets of lymphocytes
in the spleen as part of the disease process
(de Sousa et al., 1977). The data reported
us
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TABLE.-NK activity ofmononuclear cellsfrom control and HD patients' spleens
Cell source
Peripheral blood
Control spleen
HD spleen (all)
HD spleen
(uninvolved)
HD spleen
(involved)
HD spleen
asymptomatic
HD spleen
symptomatic
Number
25
20
18
15
3
11
4
NK activityc
33 -6+ 2-8
11*0+ 1.5b
27- I +4-3a
29-5+4-7a
14.8d
37*2 + 46a
8.4d
E-rosette-positive
cells
60-0+ 100
52-7 + 3-2
47-8 + 5-5
52 -0 + 5.0
43 0+17-0
47-0+7 0
43-3 + 5-2
a Significantly different from control spleen value (P= <0.001).
b Significantly different from blood value (P < 0 001).
c Percentage specific cytotoxicity at an E:T ratio, 20: 1 (mean +s.e.).
d Standard error and significance not calculated on small sample.
further extend functional studies of HD
tissue to include assays of cytotoxic
capacity towards the cell line K562.
The mean values for NK activity
presented in the control peripheral blood
samples correspond well to those des-
cribed in the literature (Nelson et al.,
1977). The results presented in the
Figure represent a study of 20 control
spleens obtained incidentally to abdominal
surgery from patients without malignant
disease. These data suggest that, unlike
the situation in the mouse (Herberman &
Holden, 1978), the level of NK activity
against K562 in control spleen is signifi-
cantly below that measured in peripheral
blood. Peter et al. (1979) have similarly
demonstrated negligible cytotoxicity
against cultured melanoma targets by
cells from 2 human spleens in comparison
with peripheral blood of the same indi-
viduals.
Perhaps the most interesting observa-
tion in these data is the significant
increase in NK activity displayed by
uninvolved HD spleens over controls.
NK activity was consistently elevated
in spleens without histological evidence
of disease involvement. In respect of
normal spleen these results confirm those
of a recent study (Gupta & Fernandes,
1981) in which NK activity against
K562 target cells was found to be the
same in blood and uninvolved spleen in
untreated, adult HD patients. The data
may reflect redistribution of lympho-
cytes capable of activity in the spleen
(de Sousa et al., 1978) or local activation of
a resident population. We were unable to
examine autochthonous blood samples
from the HD patients before they had
startedtreatment. However, otherworkers
have described normal cytotoxic activity
in the blood ofpatients with HD in all but
the most advanced stages (Khol et al.,
1980; Gupta & Fernandes, 1981), an
observation in favour of local splenic
activation rather than sequestration.
Studies in a mouse model (Chang & Log,
1980) have shown a significant increase in
splenic NK activity following transplanta-
tion of a murine reticulum-cell sarcoma
and established that the effector cells
were of host origin. These authors were,
however, unable to distinguish between
local activation or mobilization of native
NK cells by locally proliferating tumour
cells.
T-lymphocyte numbers are variably
raised in HD tissue (Kaur et al., 1974;
Payne et al., 1976; de Sousa et al., 1977)
and variable numbers of lymphoblasts
are also present (Payne et al., 1976;
Bjorkholm et al., 1981). It is clear from
the SRBC rosetting data presented that
an overall increase in the T-lymphocyte
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percentage present does not account for
the differences in cytotoxicity observed.
The HD spleens studies in this paper
showed raised T, and depressed Ty
values in comparison with controls (Payne
et al., in preparation). Other studies ofT,
and Ty levels in HD tissue (Romagnani
et al., 1978) and observations of T-
lymphocyte subset locomotor responses
to casein in normal and HD patients
(Gupta & Tan, 1980) provided over-
whelming evidence that the Tpt lympho-
cyte subset is the sequestered or expanded
subpopulation in HD spleen. This observa-
tion is not in keeping with splenic localiza-
tion of human native NK effectors which
usually express the Fcy receptor. Further,
it is now clear that polyclonally activated
lymphocytes derived from T,u, Ty or T
null subsets may kill NK-sensitive targets
(Masucci et al., 1980). Spontaneously
activated lymphocytes are present in
uninvolved HD spleen (Payne et al.,
1976; Bjorkholm et al., 1981; Payne et al.,
1980), suggesting local activation of T
cells in the spleen early in Hodgkin's
disease. Further, T cells activated to-
wards cytotoxicity are able to bind non-
selectively to a variety of allogeneic cell
types (Galili et al., 1980). These cells are
present in HD tissue (Galili et al., 1980;
Payne et al., 1980). Increased cytotoxicity
may therefore represent local activation
of lymphocytes in the spleen in relation
to the disease pathogenesis.
Grossly elevated NK activity in the
spleen is a feature of early HD. While
the availability of spleens from patients
with advanced disease is limited, en-
hanced cytotoxicity is apparently less
evident in those with histologically identi-
fiable tumour, or with B-symptoms-a
poor prognostic indicator (Carbone et al.,
1971). Serum macromolecular C3 and
Clq binding activity are known to be
elevated in patients with constitutional
symptoms (Amlot et al., 1978) and
complexes can modulate the cytotoxic
activities studied (Herberman & Holden,
1978). Tumour involvement changes the
pattern oflymphocyte activation observed
in HD spleen and may result in the
activation of cells capable of modulating
NK activity; such cells are recognized in
breast carcinoma (Eremin et al., 1981).
The nature ofthe regulatory imbalances
present in HD spleen and the characteris-
tics of and factors influencing the NK
effectors are currently under investigation
in this laboratory.
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